Positive, again! What to make of "re-positive" SARS-CoV-2 molecular test results.
Viviana Simon, Harm van Bakel, Emilia Mia Sordillo
Author Information
- Viviana Simon: Department of Microbiology, Division of Infectious Diseases, Department of Medicine and The Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States. Electronic address: viviana.simon@mssm.edu.
- Harm van Bakel: Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
- Emilia Mia Sordillo: Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, United States.
No abstract text available.
- Euro Surveill. 2020 Jun;25(24):
[PMID: 32583765]
- Emerg Infect Dis. 2020 Aug;26(8):1834-1838
[PMID: 32383638]
- Sci Rep. 2020 Jul 17;10(1):11887
[PMID: 32681141]
- N Engl J Med. 2020 Feb 20;382(8):727-733
[PMID: 31978945]
- EBioMedicine. 2020 Sep;59:102960
[PMID: 32853988]
- Lancet. 2020 Mar 28;395(10229):1054-1062
[PMID: 32171076]
- Euro Surveill. 2020 Jul;25(30):
[PMID: 32734855]
- Nature. 2020 May;581(7809):465-469
[PMID: 32235945]
- Ann Intern Med. 2020 Aug 4;173(3):242-243
[PMID: 32302380]
- J Infect. 2020 Aug;81(2):318-356
[PMID: 32283147]
- 75N93019C00051/NIAID NIH HHS
- HHSN272201400008C/NIAID NIH HHS
Betacoronavirus
COVID-19
Coronavirus Infections
Humans
Nucleic Acid Amplification Techniques
Pandemics
Pneumonia, Viral
RNA, Viral
SARS-CoV-2
